Skip to main content
SpringerLink
Log in

Tumor Suppressors APC and VHL: Gatekeepers of the Intestine and Kidney

  • Chapter
Developmental Biology of Neoplastic Growth

Part of the book series: Progress in Molecular and Subcellular Biology ((PMSB,volume 40))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Cancer Society (2002) www.cancer.org

    Google Scholar 

  • Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, Leitao CN, Fodde R, Smits R (2002) The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 11:1549–1560

    Article  PubMed  Google Scholar 

  • Ang, SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell PH, Stockton DW, Semenza GL, Prchal JT (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:614–621

    Article  PubMed  Google Scholar 

  • Aso T, Lane WS, Conaway JW, Conaway RC (1995) Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 269:1439–1443

    PubMed  Google Scholar 

  • Batlle E, Henderson JT, Beghtel H, van den Born MM. W, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H (2002) Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of the EPHB/EphrinB system. Cell 111:251–263

    Article  PubMed  Google Scholar 

  • Beerepoot LV, Shima DT, Kuroki M, Yeo KT, Voest EE (1996) Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res 56:3747–3751

    PubMed  Google Scholar 

  • Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382:225–230

    Article  PubMed  Google Scholar 

  • Blankenship C, Naglich JG, Whaley JM, Seizinger B, Kley N (1999) Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor-suppressor activity. Oncogene 18:1529–1535

    Article  PubMed  Google Scholar 

  • Bluyssen HA, Lolkema MP, van Beest M, Boone M, Snijckers CM, Los M, Gebbink MF, Braam B, Holstege FC, Giles RH, Voest EE (2004) Fibronectin is a hypoxia-independent target of the tumor suppressor VHL. FEBS Lett 556:137–142

    Article  PubMed  Google Scholar 

  • Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485–490

    Article  PubMed  Google Scholar 

  • Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Boker T, Augustin A, Kadmon M, Moslein G, Thomas G et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337–340

    PubMed  Google Scholar 

  • Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G et al (1995) Germline mutations in the von Hippel-Lindau disease tumor-suppressor gene: correlations with phenotype. Hum Mutat 5:66–75

    Article  PubMed  Google Scholar 

  • Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH, Ratcliffe PJ, Maher ER (2001) Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 10:1029–1038

    Article  PubMed  Google Scholar 

  • Dale TC (1998) Signal transduction by the Wnt family of ligands. Biochem J 329:209–223

    PubMed  Google Scholar 

  • Davidowitz EJ, Schoenfeld AR, Burk RD (2001) VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling. Mol Cell Biol 21:865–874

    Article  PubMed  Google Scholar 

  • Deka J, Kuhlmann J, Muller O (1998) A domain within the tumor-suppressor protein APC shows very similar biochemical properties as the microtubule-associated protein tau. Eur J Biochem 253:591–597

    Article  PubMed  Google Scholar 

  • Dihlmann S, Gebert J, Siermann A, Herfarth C, von Knebel Doeberitz M (1999) Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis. Cancer Res 59:1857–1860

    PubMed  Google Scholar 

  • Duan DR, Humphrey JS, Chen DY, Weng Y, Sukegawa J, Lee S, Gnarra JR, Linehan WM, Klausner RD (1995) Characterization of the VHL tumor-suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci USA 92:6459–6463

    PubMed  Google Scholar 

  • Duensing S, Munger K (2001) Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta 2:M81–M88

    Google Scholar 

  • Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10:721–733

    Article  PubMed  Google Scholar 

  • Fodde R (2002) The APC gene in colorectal cancer. Eur J Cancer 38:867–871

    Article  PubMed  Google Scholar 

  • Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan PM et al. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91:8969–8973

    PubMed  Google Scholar 

  • Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, van Es JH, Breukel C, Wiegant J, Giles RH, Clevers H (2001) Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3:433–438

    Article  PubMed  Google Scholar 

  • Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA et al (1994) Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3:2169–2173

    PubMed  Google Scholar 

  • Friedrich CA (2001) Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 10:763–767

    Article  PubMed  Google Scholar 

  • Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G, Ried T (2000) Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer 27:183–190

    Article  PubMed  Google Scholar 

  • Gijtenbeek JM, Jacobs B, Sprenger SH, Eleveld MJ, van Kessel AG, Kros JM, Sciot R, van Calenbergh F, Wesseling P, Jeuken JW (2002) Analysis of von Hippel-Lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. J Neurosurg 97:977–982

    PubMed  Google Scholar 

  • Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM et al (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85–90

    Article  PubMed  Google Scholar 

  • Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, Emmert-Buck MR, Westphal H, Klausner RD, Linehan WM (1997) Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 94:9102–9107

    Article  PubMed  Google Scholar 

  • Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT, Polyakova LA (2004) Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103:3924–3932

    Article  PubMed  Google Scholar 

  • Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600

    Article  PubMed  Google Scholar 

  • Haase VH, Glickman JN, Socolovsky M, Jaenisch R (2001) Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 98:1583–1588

    Article  PubMed  Google Scholar 

  • Hajra KM, Fearon ER (2002) Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34:255–268

    Article  PubMed  Google Scholar 

  • Halberg RB, Katzung DS, Hoff PD, Moser AR, Cole CE, Lubet RA, Donehower LA, Jacoby RF, Dove WF (2000) Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci USA 97:3461–3466

    Article  PubMed  Google Scholar 

  • Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18:5931–5942

    Article  PubMed  Google Scholar 

  • Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P (1998) Downregulation of beta-catenin by human axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8:573–581

    Article  PubMed  Google Scholar 

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512

    Article  PubMed  Google Scholar 

  • He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H (1997) A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 275:1652–1654

    Article  PubMed  Google Scholar 

  • Henderson BR (2000) Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2:653–660

    Article  PubMed  Google Scholar 

  • Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W (2003) Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 5:64–70

    Article  PubMed  Google Scholar 

  • Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM et al (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700–9704

    PubMed  Google Scholar 

  • Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG Jr (2001) von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 10:1019–1027

    Article  PubMed  Google Scholar 

  • Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr (1995) Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1:822–826

    Article  PubMed  Google Scholar 

  • Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93:10595–10599

    Article  PubMed  Google Scholar 

  • Iliopoulos O, Ohh M, Kaelin WG Jr (1998) pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci USA 95:11661–11666

    Article  PubMed  Google Scholar 

  • Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, Pause A (1999) Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 96:12436–12441

    Article  PubMed  Google Scholar 

  • Jarrett CR, Blancato J, Cao T, Bressette DS, Cepeda M, Young PE, King CR, Byers SW (2001) Human APC2 localization and allelic imbalance. Cancer Res 61:7978–7984

    PubMed  Google Scholar 

  • Jimbo T, Kawasaki Y, Koyama R, Sato R, Takada S, Haraguchi K, Akiyama T (2002) Identification of a link between the tumour suppressor APC and the kinesin superfamily. Nat Cell Biol 4:323–327

    Article  PubMed  Google Scholar 

  • Joslyn G, Richardson DS, White R, Alber T (1993) Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci USA 90:11109–11113

    PubMed  Google Scholar 

  • Kaelin WG Jr (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2:673–682

    Article  PubMed  Google Scholar 

  • Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin WG Jr, Elledge SJ, Conaway RC, Harper JW, Conaway JW (1999) Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284:657–661

    Article  PubMed  Google Scholar 

  • Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, Nathke IS (2001) A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat Cell Biol 3:429–432

    Article  PubMed  Google Scholar 

  • Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y, Higuchi O, Akiyama T (2000) Asef, a link between the tumor suppressor APC and G-protein signaling. Science 289:1194–1197

    PubMed  Google Scholar 

  • Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr (1995) Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269:1444–1446

    PubMed  Google Scholar 

  • Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo M, Roberts S, Smits R, Fodde R (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 32:594–605

    Article  PubMed  Google Scholar 

  • Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170

    Article  PubMed  Google Scholar 

  • Kinzler KW, Vogelstein B (1998) Landscaping the cancer terrain. Science 280:1036–1037

    Article  PubMed  Google Scholar 

  • Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM (1996) cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 85:829–839

    Article  Google Scholar 

  • Kishida T, Stackhouse TM, Chen F, Lerman MI, Zbar B (1995) Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544–4548

    PubMed  Google Scholar 

  • Kongkanuntn R, Bubb VJ, Sansom OJ, Wyllie AH, Harrison DJ, Clarke AR (1999) Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice. Oncogene 18:7219–7225

    Article  PubMed  Google Scholar 

  • Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM, Stearman R, Vasselli JR, Stetler-Stevenson WG, Kaelin WG Jr, Linehan WM, Klausner RD, Gnarra JR, Vande Woude GF (1999) The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol 19:5902–5912

    PubMed  Google Scholar 

  • Kuo KK, Sato N, Mizumoto K, Maehara N, Yonemasu H, Ker CG, Sheen PC, Tanaka M (2000) Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts. Hepatology 31:59–64

    Article  PubMed  Google Scholar 

  • Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, Frayling I, Efstathiou J, Pack K, Payne S, Roylance R, Gorman P, Sheer D, Neale K, Phillips R, Talbot I, Bodmer W, Tomlinson I (1999) The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's ‘two-hit’ hypothesis. Nat Med 5:1071–1075

    Article  PubMed  Google Scholar 

  • Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317–1320

    PubMed  Google Scholar 

  • Laurent-Puig P, Beroud C, Soussi T (1998) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 26:269–270

    PubMed  Google Scholar 

  • Lee S, Chen DY, Humphrey JS, Gnarra JR, Linehan WM, Klausner RD (1996) Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA 93:1770–1775

    Article  PubMed  Google Scholar 

  • Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386:623–627

    Article  PubMed  Google Scholar 

  • Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643–649

    Article  PubMed  Google Scholar 

  • Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B, Kinzler KW (1994) Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54:5953–5958

    PubMed  Google Scholar 

  • Li G, Cottier M, Sabido O, Gentil-Perret A, Lambert C, Passebosc-Faure K, Genin C, Tostain J (2002) The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma. In Vivo 16:341–344

    PubMed  Google Scholar 

  • Lieubeau-Teillet B, Rak J, Jothy S, Iliopoulos O, Kaelin W, Kerbel RS (1998) von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids. Cancer Res 58:4957–4962

    PubMed  Google Scholar 

  • Lindblom A (2001) Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 13:63–69

    Article  PubMed  Google Scholar 

  • Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, Kaelin WG Jr (1998) Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol Cell Biol 18:732–741

    PubMed  Google Scholar 

  • Los M, Aarsman CJ, Terpstra L, Wittebol-Post D, Lips CJ, Blijham GH, Voest EE (1997) Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. Ann Oncol 8:1015–1022

    Article  PubMed  Google Scholar 

  • Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z (1996) Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 149:2089–2094

    PubMed  Google Scholar 

  • Luongo C, Moser AR, Gledhill S, Dove WF (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54:5947–5952

    PubMed  Google Scholar 

  • Maher, ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–1163

    PubMed  Google Scholar 

  • Mahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A, Bertagnolli MM (1997) Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res 57:5045–5050

    PubMed  Google Scholar 

  • Mahmoud NN, Bilinski RT, Churchill MR, Edelmann W, Kucherlapati R, Bertagnolli MM (1999) Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. Cancer Res 59:353–359

    PubMed  Google Scholar 

  • Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D (2001) Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical Wnt signaling pathway. Mol Cell 7:801–809

    Article  PubMed  Google Scholar 

  • Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275

    Article  PubMed  Google Scholar 

  • Melmon KL, Rosen SW (1964) Lindau's disease. Review of the literature and study of a large kindred. Am J Med 36:595–617

    Article  PubMed  Google Scholar 

  • Meloni-Ehrig AM (2002) Renal cancer: cytogenetic and molecular genetic aspects. Am J Med Genet 115:164–172

    PubMed  Google Scholar 

  • Mimori-Kiyosue Y, Tsukita S (2001) Where is APC going? J Cell Biol 154:1105–1109

    Article  PubMed  Google Scholar 

  • Mimori-Kiyosue Y, Shiina N, Tsukita S (2000) Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells. J Cell Biol 148:505–518

    PubMed  Google Scholar 

  • Mogensen MM, Tucker JB, Mackie JB, Prescott AR, Nathke IS (2002) The adenomatous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells. J Cell Biol 157:1041–1048

    Article  PubMed  Google Scholar 

  • Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790

    Article  PubMed  Google Scholar 

  • Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322–324

    PubMed  Google Scholar 

  • Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN (1993) ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci USA 90:8977–8981

    PubMed  Google Scholar 

  • Moser AR, Shoemaker AR, Connelly CS, Clipson L, Gould KA, Luongo C, Dove WF, Siggers PH, Gardner RL (1995) Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev Dyn 203:422–433

    PubMed  Google Scholar 

  • Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54:3676–3681

    PubMed  Google Scholar 

  • Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92:3046–3050

    PubMed  Google Scholar 

  • Nakagawa H, Murata Y, Koyama K, Fujiyama A, Miyoshi Y, Monden M, Akiyama T, Nakamura Y (1998) Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin. Cancer Res 58:5176–5181

    PubMed  Google Scholar 

  • Nakagawa H, Koyama K, Monden M, Nakamura Y (1999) Analysis of APCL, a brain-specific adenomatous polyposis coli homologue, for mutations and expression in brain tumors. Jpn J Cancer Res 90:982–986

    PubMed  Google Scholar 

  • Nakagawa H, Koyama K, Murata Y, Morito M, Akiyama T, Nakamura Y (2000a) APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus. Cancer Res 60:101–105

    PubMed  Google Scholar 

  • Nakagawa H, Koyama K, Murata Y, Morito M, Akiyama T, Nakamura Y (2000b) EB3, a novel member of the EB1 family preferentially expressed in the central nervous system, binds to a CNS-specific APC homologue. Oncogene 19:210–216

    Article  PubMed  Google Scholar 

  • Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T (1998) Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells 3:395–403

    Article  PubMed  Google Scholar 

  • Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ (1996) The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 134:165–179

    Article  PubMed  Google Scholar 

  • Neufeld KL, Zhang F, Cullen BR, White RL (2000) APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep 1:519–523

    PubMed  Google Scholar 

  • Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665–669

    PubMed  Google Scholar 

  • Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr, Iliopoulos O (1998) The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1:959–968

    Article  PubMed  Google Scholar 

  • Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW (1997) Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272:24735–24738

    Article  PubMed  Google Scholar 

  • Oshima H, Oshima M, Kobayashi M, Tsutsumi M, Taketo MM (1997) Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice. Cancer Res 57:1644–1649

    PubMed  Google Scholar 

  • Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 92:4482–4486

    PubMed  Google Scholar 

  • Park WS, Oh RR, Park JY, Kim PJ, Shin MS, Lee JH, Kim HS, Lee SH, Kim SY, Park YG, An WG, Jang JJ, Yoo NJ, Lee JY (2001) Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193:483–490

    Article  PubMed  Google Scholar 

  • Pause A, Peterson B, Schaffar G, Stearman R, Klausner RD (1999) Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Proc Natl Acad Sci USA 96:9533–9538

    Article  PubMed  Google Scholar 

  • Peifer M, Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis — a look outside the nucleus. Science 287:1606–1609

    Article  PubMed  Google Scholar 

  • Pepe S, Ruggiero A, d'Acquisto M, de Laurentiis M, de Placido S, Sandomenico C, Staibano S, de Rosa G, Lucariello A, D'Armiento M, Bianco AR (2000) Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas. Cancer 89:1065–1075

    Article  PubMed  Google Scholar 

  • Pfander D, Kobayashi T, Knight MC, Zelzer E, Chan DA, Olsen BR, Giaccia AJ, Johnson RS, Haase VH, Schipani E (2004) Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131:2497–2508

    Article  PubMed  Google Scholar 

  • Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther M, Linehan WM, Klausner RD, Ried T (2001) Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chromosomes Cancer 31:1–9

    Article  PubMed  Google Scholar 

  • Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ (1998) Centrosome defects and genetic instability in malignant tumors. Cancer Res 58:3974–3985

    PubMed  Google Scholar 

  • Polakis P (1999) The oncogenic activation of beta-catenin. Curr Opin Genet Dev 9:15–21

    Article  PubMed  Google Scholar 

  • Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235–237

    Article  PubMed  Google Scholar 

  • Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Maher ER (1997) Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Am J Hum Genet 60:765–771

    PubMed  Google Scholar 

  • Pyles RB, Santoro IM, Groden J, Parysek LM (1998) Novel protein isoforms of the APC tumor suppressor in neural tissue. Oncogene 16:77–82

    Article  PubMed  Google Scholar 

  • Quesada CF, Kimata H, Mori M, Nishimura M, Tsuneyoshi T, Baba S (1998) Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice. Jpn J Cancer Res 89:392–396

    PubMed  Google Scholar 

  • Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJ, Phillips WA (2001) Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J Biol Chem 276:45113–45119

    Article  PubMed  Google Scholar 

  • Romagnolo B, Berrebi D, Saadi-Keddoucci S, Porteu A, Pichard AL, Peuchmaur M, Vandewalle A, Kahn A, Perret C (1999) Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res 59:3875–3879

    PubMed  Google Scholar 

  • Rosin-Arbesfeld R, Townsley F, Bienz M (2000) The APC tumour suppressor has a nuclear export function. Nature 406:1009–1012

    Article  PubMed  Google Scholar 

  • Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, Bicknell D, Bodmer WF, Tomlinson IP (2000) APC mutations in sporadic colorectal tumors: a mutational »hotspot« and interdependence of the »two hits”. Proc Natl Acad Sci USA 97:3352–3357

    Article  PubMed  Google Scholar 

  • Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P (1997) Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 57:4624–4630

    PubMed  Google Scholar 

  • Samowitz WS, Powers MD, Spirio LN, Nollet F, van Roy F, Slattery ML (1999) Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 59:1442–1444

    PubMed  Google Scholar 

  • Sasai H, Masaki M, Wakitani K (2000) Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis 21:953–958

    Article  PubMed  Google Scholar 

  • Sato N, Mizumoto K, Nakamura M, Maehara N, Minamishima YA, Nishio S, Nagai E, Tanaka M (2001) Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet Cytogenet 126:13–19

    Article  PubMed  Google Scholar 

  • Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24:245–250

    Article  PubMed  Google Scholar 

  • Semenza GL (2001) HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13:167–171

    Article  PubMed  Google Scholar 

  • Shaub A (1999) Unravelling the extracellular matrix. Nat Cell Biol 1:E173–E175

    Article  PubMed  Google Scholar 

  • Sherr, CJ (2004) Principles of tumor suppression. Cell 116:235–246

    Article  PubMed  Google Scholar 

  • Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I, Nakamura Y, Shiba K, Noda T (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278:120–123

    Article  PubMed  Google Scholar 

  • Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845

    Article  PubMed  Google Scholar 

  • Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D (1996) Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299–2301

    PubMed  Google Scholar 

  • Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B, Kinzler KW (1994) Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 54:3672–3675

    PubMed  Google Scholar 

  • Smits R, van der Houven van Oordt W, Luz A, Zurcher C, Jagmohan-Changur S, Breukel C, Khan PM, Fodde R (1998) Apc1638 N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 114:275–283

    Article  PubMed  Google Scholar 

  • Smits R, Kielman MF, Breukel C, Zurcher C, Neufeld K, Jagmohan-Changur S, Hofland N, van Dijk J, White R, Edelmann W, Kucherlapati R, Khan PM, Fodde R (1999) Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 13:1309–1321

    PubMed  Google Scholar 

  • Smits R, Hofland N, Edelmann W, Geugien M, Jagmohan-Changur S, Albuquerque C, Breukel C, Kucherlapati R, Kielman MF, Fodde R (2000) Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity. Genes Chromosomes Cancer 29:229–239

    Article  PubMed  Google Scholar 

  • Stickle NH, Chung J, Klco JM, Hill RP, Kaelin, WG Jr. Ohh M (2004) pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development. Mol Cell Biol 24:3251–3261

    Article  PubMed  Google Scholar 

  • Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668–670

    PubMed  Google Scholar 

  • Su LK, Johnson KA, Smith KJ, Hill DE, Vogelstein B, Kinzler KW (1993) Association between wild type and mutant APC gene products. Cancer Res 53:2728–2731

    PubMed  Google Scholar 

  • Su LK, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, Trent J, Vogelstein B, Kinzler KW (1995) APC binds to the novel protein EB1. Cancer Res 55:2972–2977

    PubMed  Google Scholar 

  • Su LK, Barnes CJ, Yao W, Qi Y, Lynch PM, Steinbach G (2000) Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis. Am J Hum Genet 67:582–590

    Article  PubMed  Google Scholar 

  • Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD (1995) Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res 55:6189–6195

    PubMed  Google Scholar 

  • Truong, LD, Choi YJ, Shen SS, Ayala G, Amato R, Krishnan B (2003) Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol 10:135–159.

    Article  PubMed  Google Scholar 

  • Van de Wetering M, Sancho E, Verweij C, de Lau W, Oving IM, Hurlstone A, van der Horn K, Batlle E, Coudreuse DY, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born MM. W, Soete G, Pals ST, Eilers M, Medema RH, Clevers H (2002) The beta-catenin/TCF4 complex controls the proliferation/differentiation switch in colon epithelium through c-MYC-mediated repression of p21CIP1/WAF1. Cell 111:241–250

    Article  PubMed  Google Scholar 

  • Van der Houven van Oordt CW, Smits R, Williamson SL, Luz A, Khan PM, Fodde R, van der Eb AJ, Breuer ML (1997) Intestinal and extra-intestinal tumor multiplicities in the Apc1638 N mouse model after exposure to X-rays. Carcinogenesis 18:2197–203

    Article  PubMed  Google Scholar 

  • Van Es JH, Kirkpatrick C, van de Wetering M, Molenaar M, Miles A, Kuipers J, Destree O, Peifer M, Clevers H (1999) Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. Curr Biol 9:105–108

    Article  PubMed  Google Scholar 

  • Van Es JH, Giles RH, Clevers HC (2001) The many faces of the tumor suppressor gene APC. Exp Cell Res 264:126–134

    Article  PubMed  Google Scholar 

  • Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9:138–141

    Article  PubMed  Google Scholar 

  • Wang Y, Macke JP, Abella BS, Andreasson K, Worley P, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J (1996) A large family of putative transmembrane receptors homologous to the product of the Drosophila tissue polarity gene frizzled. J Biol Chem 271:4468–4476

    Article  PubMed  Google Scholar 

  • Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407:527–530

    Article  PubMed  Google Scholar 

  • Wilkinson DG (2001) Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2:155–164

    Article  PubMed  Google Scholar 

  • Willert J, Epping M, Pollack JR, Brown PO, Nusse R (2002) A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8

    Article  PubMed  Google Scholar 

  • Wizigmann-Voos S, Breier G, Risau W, Plate KH (1995) Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55:1358–1364

    PubMed  Google Scholar 

  • Xu Q, Mellitzer G, Robinson V, Wilkinson DG (1999) In vivo cell sorting in complementary segmental domains mediated by Eph receptors and ephrins. Nature 399:267–271

    Article  PubMed  Google Scholar 

  • Yanagawa S, van Leeuwen F, Wodarz A, Klingensmith J, Nusse R (1995) The dishevelled protein is modified by wingless signaling in Drosophila. Genes Dev 9:1087–1097

    PubMed  Google Scholar 

  • Zachariae W, Shevchenko A, Andrews PD, Ciosk R, Galova M, Stark MJ, Mann M, Nasmyth K (1998) Mass spectrometric analysis of the anaphase-promoting complex from yeast: identification of a subunit related to cullins. Science 279:1216–1219

    Article  PubMed  Google Scholar 

  • Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Glavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CH, Lerman M et al (1996) Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348–357

    Article  PubMed  Google Scholar 

  • Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F (1997) The mouse Fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90:181–192

    Article  PubMed  Google Scholar 

  • Zumbrunn J, Kinoshita K, Hyman AA, Nathke IS (2001) Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation. Curr Biol 11:44–49

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Medical Oncology. Rm. F02.126, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands

    Rachel H. Giles & Emile E. Voest

Authors
  1. Rachel H. Giles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emile E. Voest
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. INSERM, 73 bis, rue du Maréchal Foch, 78000, Versailles, France

    Alvaro Macieira-Coelho

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Giles, R.H., Voest, E.E. (2005). Tumor Suppressors APC and VHL: Gatekeepers of the Intestine and Kidney. In: Macieira-Coelho, A. (eds) Developmental Biology of Neoplastic Growth. Progress in Molecular and Subcellular Biology, vol 40. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27671-8_7

Download citation

Publish with us

Policies and ethics

Search

Navigation